Voice your opinion on congressional bill HR3682-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Improving Transparency to Lower Drug Costs Act of 2021

This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.

HR19-117, S2164-117,

House committee actions Actions

Committee
Jun. 02 2021	Referred to the Subcommittee on Health.
Jun. 01 2021	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Jun. 01
2021

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Jun. 01 2021	Introduced in House Introduced in House

House bill HR3682-117

Improving Transparency to Lower Drug Costs Act of 2021

Promote the cause!

Or use this QR code